SNOA Sonoma Pharmaceuticals, Inc.
$1.31▼ -0.38%
Healthcare
Other
After hours
$1.27▼ -2.68%
Sep 11, 5:57 PM ET
Volume 21.9K
Avg Volume (10D) 55.4K
Key Metrics & Fundamentals
Market Cap
$6.25M
P/E Ratio
–
Div Yield
–%
52W Range
0.85 - 4.60
% vs 50 MA
3.98%
% vs 200 MA
-37.89%
RSI-14
51.7
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.27
Free Cash Flow
-$651,000
Gross Rev
$6.41M
Gross Profit
$2.58M
EBITDA
-$8,000
COGS
$3.83M
Operating Exp
$2.62M
Operating Income
-$40,000
EBIT
-$40,000
Pretax Income
-$330,000
Net Income
-$330,000
EPS (Diluted)
-0.09
Price & Volume History
Loading chart…
Recent News
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
ACCESS Newswire · Aug 6, 2026 1:00 PM
Sonoma Pharmaceuticals Receives FDA Approval for Microdacyn's Expanded Indications, Packaging Options
MT Newswires · Jun 30, 2026 2:00 PM
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
ACCESS Newswire · Jun 30, 2026 1:00 PM
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results
ACCESS Newswire · Jun 16, 2026 8:15 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See SNOA's money flow as a full page
Social Sentiment
No Reddit posts found for SNOA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.